Global Pharmaceuticals & Biotech Potentially Undervalued Companies

Curaleaf Holdings

Market Cap: CA$2.5b

Produces and distributes cannabis products in the United States and internationally.

Perrigo

Market Cap: €1.8b

Provides over-the-counter health and wellness solutions in the United States, Europe, and internationally.

Aspen Pharmacare Holdings

Market Cap: €42.3b

Manufactures and markets specialty and branded pharmaceutical products in Africa, the Middle East, the Americas, Europe CIS, Australasia, and Asia.

Novo Nordisk

Market Cap: R$1.4t

Engages in the research and development, manufacture, and distribution of pharmaceutical products in Europe, the Middle East, Africa, Mainland China, Hong Kong, Taiwan, North America, and internationally.

Merck KGaA

Market Cap: €50.3b

Operates as a science and technology company in Germany and internationally.

Shionogi

Market Cap: €2.3t

Engages in the research, development, manufacture, and distribution of pharmaceuticals, diagnostic reagents, and medical devices in Japan and internationally.

Johnson & Johnson

Market Cap: €500.1b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Royalty Pharma

Market Cap: €23.0b

Operates as a buyer of biopharmaceutical royalties and a funder of innovation in the biopharmaceutical industry in the United States.

Otsuka Holdings

Market Cap: €4.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

TerrAscend

Market Cap: €228.8m

TerrAscend Corp. cultivates, produces, and sells cannabis products in Canada and the United States.

Planet 13 Holdings

Market Cap: CA$89.5m

Planet 13 Holdings Inc., together with its subsidiaries, cultivates and provides cannabis and cannabis-infused products for medical and retail cannabis markets in the United States.

Trulieve Cannabis

Market Cap: €1.3b

Operates as a cannabis retailer.

Regeneron Pharmaceuticals

Market Cap: €80.5b

Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide.

Pharming Group

Market Cap: €996.9m

A biopharmaceutical company, develops and commercializes protein replacement therapies and precision medicines for the treatment of rare diseases in the United States, Europe, and internationally.

Novartis

Market Cap: CHF 200.8b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

Novartis

Market Cap: €200.8b

Researches, develops, manufactures, distributes, markets, and sells pharmaceutical medicines in Switzerland and internationally.

HUTCHMED (China)

Market Cap: €1.9b

HUTCHMED (China) Limited, together with its subsidiaries, discovers, develops, and commercializes targeted therapeutics and immunotherapies to treat cancer and immunological diseases in Hong Kong, the United States, and internationally.

Evotec

Market Cap: US$1.0b

Operates as a drug discovery and development company in the United States, Germany, France, the United Kingdom, Switzerland, and internationally.

Merck KGaA

Market Cap: US$50.3b

Operates as a science and technology company in Germany and internationally.

Viatris

Market Cap: US$12.3b

Operates as a healthcare company in North America, Europe, China, Taiwan, Hong Kong, Japan, Australia, New Zealand, rest of Asia, Africa, Latin America, and the Middle East.

Cresco Labs

Market Cap: US$470.9m

Cresco Labs Inc. cultivates, manufactures, and sells retail and medical cannabis products in the United States and Germany.

Trulieve Cannabis

Market Cap: US$1.3b

Operates as a cannabis retailer.

Iovance Biotherapeutics

Market Cap: US$968.6m

A commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States.

Amphastar Pharmaceuticals

Market Cap: US$1.3b

A bio-pharmaceutical company, develops, manufactures, markets, and sells generic and proprietary injectable, inhalation, and intranasal products in the United States, China, and France.

TG Therapeutics

Market Cap: US$4.9b

A commercial stage biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel treatments for B-cell mediated diseases in the United States and internationally.

Sarepta Therapeutics

Market Cap: US$2.2b

A commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases.

Halozyme Therapeutics

Market Cap: US$8.5b

A biopharmaceutical company, researches, develops, and commercializes of proprietary enzymes and devices in the United States and internationally.

Exelixis

Market Cap: US$11.9b

An oncology company, focuses on the discovery, development, and commercialization of new medicines for difficult-to-treat cancers in the United States.

GSK

Market Cap: UK£72.4b

Engages in the research, development, and manufacture of vaccines, specialty medicines, and general medicines to prevent and treat disease in the United Kingdom, the United States, and internationally.

Otsuka Holdings

Market Cap: JP¥4.7t

Engages in the pharmaceuticals, nutraceuticals, consumer products, and other businesses worldwide.

CSL

Market Cap: US$89.9b

Engages in the research, development, manufacture, market, and distribution of biopharmaceutical products and vaccines in Australia, the United States, Germany, the United Kingdom, Switzerland, China, Hong Kong, and internationally.

Johnson & Johnson

Market Cap: R$500.1b

Engages in the research and development, manufacture, and sale of various products in the healthcare field worldwide.

Telix Pharmaceuticals

Market Cap: US$5.2b

A commercial-stage biopharmaceutical company, focuses on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals.

Bayer

Market Cap: US$30.1b

Operates as a life science company worldwide.

Abeona Therapeutics

Market Cap: US$279.1m

A clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening diseases.

Takeda Pharmaceutical

Market Cap: JP¥7.1t

Engages in the research, development, manufacture, marketing, and out-licensing of pharmaceutical products in Japan and internationally.